Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and efficacy of ceftazidime-avibactam in CRE meningitis/ventriculitis
ChiCTR2500112437Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Nov 2025
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftazidime + avibactam in meningitis and ventriculitis, sponsored by Huashan Hospital. Primary endpoints: Blood pharmacokinetic parameters, Cerebrospinal fluid pharmacokinetic parameters and 1 more. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
ceftazidime + avibactam
03
Conditions
meningitisventriculitis
Beyond the preview
Go deeper on ChiCTR2500112437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112437.